Skip to content

Author

Alan Raj

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

CK2 in triple-negative breast cancer: oncogenic signaling networks and emerging CK2 inhibitor-based combination therapies.

The complex role of aberrant CK2 signaling in TNBC progression is highlighted and the therapeutic promise of CK2 inhibitor-based combination therapies to overcome resistance and improve treatment efficacy is examined.

Navas Shereef Ellyan, A. T. Alex, U. Nayak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.